Tenax Therapeutics, Inc. (TENX)
NASDAQ: TENX · Real-Time Price · USD
5.38
+0.28 (5.49%)
Apr 23, 2025, 4:00 PM EDT - Market closed
Tenax Therapeutics Employees
As of December 31, 2024, Tenax Therapeutics had 6 total employees, including 5 full-time and 1 part-time employees. The number of employees did not change compared to the previous year.
Employees
6
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$2,933,667
Market Cap
192.89M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novartis AG | 75,883 |
TENX News
- 7 days ago - Tenax: Phase 3 Heart Failure Program Continues With 2 Key Catalysts - Seeking Alpha
- 23 days ago - Tenax Therapeutics to Participate in the 24th Annual Needham Virtual Healthcare Conference - GlobeNewsWire
- 4 weeks ago - Tenax Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update - GlobeNewsWire
- 7 weeks ago - Tenax Therapeutics Announces $25 Million Private Placement - GlobeNewsWire
- 7 weeks ago - Tenax Therapeutics Expands Phase 3 LEVEL Program, Advancing Two TNX-103 (Oral Levosimendan) Registrational Studies for the Treatment of PH-HFpEF - GlobeNewsWire
- 7 weeks ago - Tenax Therapeutics to Participate in the Leerink Partners 2025 Global Healthcare Conference - GlobeNewsWire
- 2 months ago - Tenax Therapeutics to Participate in the Guggenheim SMID Cap Biotech Conference - GlobeNewsWire
- 5 months ago - Tenax Therapeutics, Inc. (TENX) Guggenheim Healthcare Innovation Conference (Transcript) - Seeking Alpha